We also found novel trans-enhancer hijacking events activating known oncogenes including MYC in the small cell lung cancer cell line NCIH146, NOTCH1 in the T-cell lymphoblastic leukemia cell line CUTLL1, and CCND1 in the breast cancer cell line ZR751. This evidence concerns the gene CCND1 and small cell lung carcinoma.